← Back to Clinical Trials
Recruiting NCT06433349

NCT06433349 A Multi-center Investigation of Family Health.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06433349
Status Recruiting
Phase
Sponsor Odense University Hospital
Condition Breast Cancer
Study Type OBSERVATIONAL
Enrollment 240 participants
Start Date 2024-05-13
Primary Completion 2026-05-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Survey and interviews

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 240 participants in total. It began in 2024-05-13 with a primary completion date of 2026-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The current healthcare system is unable to identify burdened and vulnerable families affected by cancer, partly due to a lack of knowledge of how cancer affects family health during treatment and survivorship. Recent reviews have documented a general lack of cancer studies including both the patient and the family, and a particular deficiency in studies including more than the spouse. The principal aim of this study is to investigate family health, needs and perceived support, quality of life, self-efficacy, depression, stress and resilience in both patients with cancer and their families across the cancer trajectory. Additionally, the study seeks to identify particularly burdened and vulnerable families and investigate contributing factors to their vulnerability.

Eligibility Criteria

Inclusion Criteria: * curative intended patients and their eventual appointed caregivers \>18 * breast-, prostate- colorectal cancer or lymphoma. Exclusion Criteria: * Not able to understand or give written informed consent * Not able to speak Danish or complete questionnaires in Danish

Contact & Investigator

Central Contact

Lærke K. Tolstrup, PhD

✉ laerke.tolstrup@rsyd.dk

📞 +4540295129

Frequently Asked Questions

Who can join the NCT06433349 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06433349 currently recruiting?

Yes, NCT06433349 is actively recruiting participants. Contact the research team at laerke.tolstrup@rsyd.dk for enrollment information.

Where is the NCT06433349 trial being conducted?

This trial is being conducted at Odense C, Denmark.

Who is sponsoring the NCT06433349 clinical trial?

NCT06433349 is sponsored by Odense University Hospital. The trial plans to enroll 240 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology